FDA Adverse Event Malfunction Summary report: N

NXTAG COV EXTENDED PANEL

MDR report key: 12021166 · Received June 17, 2021

Report

Report Number
3002777243-2021-00002
Event Type
Malfunction
Date Received
June 17, 2021
Date of Event
February 22, 2021
Report Date
June 10, 2021
Manufacturer
LUMINEX MOLECULAR DIAGNOSTICS, INC.
Product Code
QJR
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THERE WAS NO REPORTED INJURY OR DEATH AT THE TIME OF THIS REPORT. THE MDR IS BEING SUBMITTED UNDER DEVIATION (B)(4). PURSUANT TO THE OBLIGATIONS OF THE EMERGENCY USE AUTHORIZATION, AND PER COMMUNICATION RECEIVED FROM FDA ON OCTOBER 7, 2020.

Description of Event or Problem · 1

ON (B)(6) 2021, THE CUSTOMER REPORTED THAT THEY HAVE RECENTLY SEEN SOME SAMPLES COME UP POSITIVE FOR ONLY ORF1AB AND E GENES WITH STRONG SIGNALS, BUT NO SIGNAL FOR THE N GENE. THEY WERE CURIOUS IF THIS WAS A RESULT OF THE NEW VARIANT GENE. TECHNICAL SUPPORT NOTED THAT THIS IS NOT A DISCREPANCY SINCE ONLY 1 TARGET NEEDS TO BE POSITIVE (N, ORF1AB, OR P GENE) IN ORDER TO GET COV POSITIVE. TECHNICAL SUPPORT REQUESTED THE DATA AND CHECKED TO SEE IF THE CUSTOMER COULD SHIP THE SAMPLES IN QUESTION TO LUMINEX FOR VARIANT EVALUATION. ON (B)(6) 2021, THE CUSTOMER NOTIFIED TECHNICAL SUPPORT THAT THEY WILL BE REPEATING THE SAMPLES THAT WERE POTENTIAL VARIANTS (NO N GENE DETECTED) AND WILL SHIP THESE SAMPLES TO LUMINEX FOR POTENTIAL SEQUENCING IF THE RESULTS REPEAT. CONCLUSION: ON (B)(6) 2021, THE CUSTOMER CONFIRMED THAT ALL THE REPEATS CAME BACK NEGATIVE SO THEY WILL NOT SEND THE SAMPLES TO LUMINEX FOR SEQUENCING. CUSTOMER ALSO CONFIRMED THAT ALL THE POSITIVE CONTROLS/INTERNAL CONTROLS WERE FINE. FURTHER INVESTIGATION WAS NOT NEEDED ANYMORE. AT THIS TIME, THIS CASE WILL BE SUBMITTED AS AN MDR BASED ON FDA'S GUIDANCE RECEIVED ON OCTOBER 7TH, 2020.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
918630 NXTAG COV EXTENDED PANEL NXTAG COV EXTENDED PANEL QJR LUMINEX MOLECULAR DIAGNOSTICS, INC. IK054C-0050, IK054C-0051

Patients

Seq Age Sex Outcome Treatment
1